ReviewDer Radiologe2021
[Artificial intelligence in breast imaging : Areas of application from a clinical perspective].
Review in Der Radiologe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
- Multimodal Imaging of Target Detection Algorithm under Artificial Intelligence in the Diagnosis of Early Breast Cancer.Journal of healthcare engineering · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical/methodological issueCentral to breast imaging is the coordination of clinical and multimodal imaging information with percutaneous image-guided biopsies and surgical procedures. A wide range of problems arise due to this complexity: missed cancers, overdiagnosis, false-positive findings, unnecessary further imaging, biopsies and surgeries. STANDARD RADIOLOGICAL
methodsBreast imaging comprises the following diagnostic tests: mammography, tomosynthesis, contrast-enhanced mammography, (multiparametric) ultrasound, magnetic resonance imaging, computed tomography, nuclear medicine derived imaging and hybrid methods. METHODOLOGICAL INNOVATIONS: Artificial intelligence (AI) promises to alleviate practically all these problems of breast imaging. AI has the potential to avoid missed cancers and false-positive findings. Furthermore, it could guide an efficient use of imaging methods and it may potentially be used to define biological phenotypes of breast cancer. PERFORMANCE: AI-based software is being developed for various applications. Most developed are systems that support mammography screening. Problems are monocentric approaches and the focus on short-term financial success. ACHIEVEMENTS: AI promises to improve breast imaging by simplifying and speeding up the workflow, by reducing monotonous tasks and by pointing out problems. This is likely to set free physician capacities that could be invested in improved communication with patients and interdisciplinary colleagues. PRACTICAL RECOMMENDATIONS: The present article mainly addresses clinical needs in breast imaging, pointing out potential areas of use for artificial intelligence. Depending on the definition, a wide array of helpful software tools for breast imaging are already available. Global solutions, however, are still missing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.